Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Cash from Operations (2016 - 2025)

Historic Cash from Operations for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to -$64000.0.

  • STRATA Skin Sciences' Cash from Operations rose 7880.79% to -$64000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 million, marking a year-over-year decrease of 31635.51%. This contributed to the annual value of $188000.0 for FY2024, which is 13622.35% up from last year.
  • As of Q3 2025, STRATA Skin Sciences' Cash from Operations stood at -$64000.0, which was up 7880.79% from -$1.9 million recorded in Q2 2025.
  • Over the past 5 years, STRATA Skin Sciences' Cash from Operations peaked at $1.4 million during Q4 2023, and registered a low of -$2.0 million during Q3 2023.
  • For the 5-year period, STRATA Skin Sciences' Cash from Operations averaged around -$121157.9, with its median value being -$56000.0 (2022).
  • Per our database at Business Quant, STRATA Skin Sciences' Cash from Operations soared by 179107.14% in 2023 and then plummeted by 42842.64% in 2025.
  • Over the past 5 years, STRATA Skin Sciences' Cash from Operations (Quarter) stood at $669000.0 in 2021, then tumbled by 73.24% to $179000.0 in 2022, then skyrocketed by 665.92% to $1.4 million in 2023, then tumbled by 48.72% to $703000.0 in 2024, then tumbled by 109.1% to -$64000.0 in 2025.
  • Its Cash from Operations stands at -$64000.0 for Q3 2025, versus -$1.9 million for Q2 2025 and -$550000.0 for Q1 2025.